V Foundation   Report issue

Foundation Phase 1 Phase 2
Founded: Cary NC United States (1993)

Organization Overview

First Clinical Trial
2008
NCT00876993
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

The V Foundation | The V Foundation for Cancer Research | V Foundation

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Adenoid Cystic (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Central Nervous System Neoplasms (Phase 1)

Glioma (Phase 1)

Head and Neck Neoplasms (Phase 2)

Immune System Diseases (Phase 1)

Immunoproliferative Disorders (Phase 1)

Lymphatic Diseases (Phase 1)

Lymphoma (Phase 1)

Lymphoma, B-Cell (Phase 1)

Neoplasms (Phase 2)

Nervous System Neoplasms (Phase 1)

Neuroendocrine Tumors (Phase 2)

Pancreatic Neoplasms (Phase 2)

Peripheral Nervous System Diseases (Phase 2)

Prostatic Neoplasms (Phase 1)

Sarcoma (Phase 1)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 14
  • # of Trial APIs: 23